ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
6,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
7,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
7,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
8,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
9,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
9,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
11,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
11,2,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
12,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
12,3,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
12,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
12,5,Metastases to muscle,Metastases to specified sites,Metastases,Neopl,N
12,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
13,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
14,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
14,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
15,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
15,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
15,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
15,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
15,5,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
15,6,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
15,7,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
15,9,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
15,12,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
16,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
17,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
18,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
18,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
18,4,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
18,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
19,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
19,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
19,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
20,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
21,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
21,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
22,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
23,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
23,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
24,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
24,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
24,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
24,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
24,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
24,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
25,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
25,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
25,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
25,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
25,5,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
25,6,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
25,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,8,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
26,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
27,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
28,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
28,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
28,4,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
28,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
28,6,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
28,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
29,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
29,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
29,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
29,5,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
30,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
31,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
31,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
32,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
32,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
32,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
32,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
32,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
32,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
32,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
33,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
33,2,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
33,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
33,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
34,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
34,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
35,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
35,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
36,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
37,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
37,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
38,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
38,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
38,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
39,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
39,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
39,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
40,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
40,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
40,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
40,4,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
40,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
41,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
42,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
43,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
45,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
45,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
45,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
46,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
47,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
47,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
47,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
48,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
49,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
49,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
49,3,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
49,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
50,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
50,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
51,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
51,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
51,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
51,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
52,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
53,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
54,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
55,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
55,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
56,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
57,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
58,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
58,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
58,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
59,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
60,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
61,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
62,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
63,1,Blood cholesterol abnormal,Cholesterol analyses,Lipid analyses,Inv,N
63,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
64,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
64,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
65,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
65,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
65,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
65,4,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
66,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
67,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
67,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
67,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
68,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
69,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
69,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
70,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
